During the past decade, WellSpan Health-York Hospital conducted 89 clinical trials. In the 10-year time frame, 89 clinical trials started and 88 clinical trials were completed, i.e. on average, 98.9% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 41 clinical trials were completed. i.e. 186.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "WellSpan Health-York Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 55 trials, followed by "Radiation Therapy Oncology Group" with 32 trials sponsored, "Alliance for Clinical Trials in Oncology" with 19 trials sponsored, "SWOG Cancer Research Network" with 16 trials sponsored and "Boston Scientific Corporation" with 16 trials sponsored. Other sponsors include 84 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "WellSpan Health-York Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 90 trials as a collaborator, "NRG Oncology" with 27 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "North Central Cancer Treatment Group" with 6 trials as a collaborator and "Cancer and Leukemia Group B" with 5 trials as a collaborator. Other collaborators include 77 different institutions and companies that were collaborators in the rest 61 trials.

According to Clinical.Site data, the most researched conditions in "WellSpan Health-York Hospital" are "Coronary Artery Disease" (11 trials), "Prostate Cancer" (11 trials), "Breast Cancer" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials) and "Stage IV Lung Cancer AJCC v8" (8 trials). Many other conditions were trialed in "WellSpan Health-York Hospital" in a lesser frequency.

Most popular intervention types in "WellSpan Health-York Hospital" are "Drug" (137 trials), "Other" (91 trials), "Biological" (52 trials), "Procedure" (48 trials) and "Device" (46 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (51 trials), "Quality-of-Life Assessment" (35 trials), "Paclitaxel" (19 trials), "radiation therapy" (18 trials) and "Questionnaire Administration" (17 trials). Other intervention names were less common.

The vast majority of trials in "WellSpan Health-York Hospital" are 175 trials for "All" genders, 38 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "WellSpan Health-York Hospital". undefined are not yet recruiting, 25 are recruiting, 78 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 95 completed trials in WellSpan Health-York Hospital, 3 suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in WellSpan Health-York Hospital, 9 "Phase 1" clinical trials were conducted, 60 "Phase 2" clinical trials and 110 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 37 trials that are defined as “Not Applicable".

WellSpan Health-York Hospital has several departments that took part in Clinical trials: "Adams Cancer Center" - 129 trials, "WellSpan Health-York Cancer Center" - 155 trials, "Sechler Family Cancer Center" - 67 trials, "WellSpan Medical Oncology and Hematology" - 13 trials, "Wellspan Lung, Sleep and Critical Care" - 2 trials, "WellSpan Heart & Vascular" - 2 trials, "WellSpan Gynecologic Oncology" - 2 trials